Thomas Lindsay

Thomas Lindsay

Director/Board Member at GENEDRIVE PLC

Net worth: 85 876 $ as of 31/05/2026

69 year
Health Technology
Consumer Services
Distribution Services

Profile

Thomas Lindsay is currently an Independent Non-Executive Director at Trinity Biotech Plc since 2022 and at Genedrive Plc since 2018.
Previously, he served as a Non-Executive Director at Nigerian-German Chemicals Plc and as the President-Commercial Operations at Abbott Rapid Diagnostics ULC.
Mr. Lindsay completed his undergraduate degree at Glasgow Caledonian University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
24/09/2025 4,901,605 ( 0.31% ) 85 876 $ 31/05/2026

Thomas Lindsay active positions

CompaniesPositionStart
GENEDRIVE PLC Director/Board Member 09/04/2018
TRINITY BIOTECH PLC Director/Board Member 26/10/2022

Former positions of Thomas Lindsay

CompaniesPositionEnd
Corporate Officer/Principal 01/01/2017
NIGERIAN-GERMAN CHEMICALS PLC Director/Board Member -
See the detail of Thomas Lindsay's experience

Training of Thomas Lindsay

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

8

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Health Technology

Distribution Services

  1. Stock Market
  2. Insiders
  3. Thomas Lindsay
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!